Shagun Singh
Stock Analyst at RBC Capital
(3.28)
# 989
Out of 5,182 analysts
253
Total ratings
48.82%
Success rate
0.73%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JNJ Johnson & Johnson | Reiterates: Outperform | $255 | $238.41 | +6.96% | 25 | Mar 30, 2026 | |
| BSX Boston Scientific | Reiterates: Outperform | $115 | $61.86 | +85.90% | 20 | Mar 30, 2026 | |
| TFX Teleflex | Maintains: Sector Perform | $115 → $125 | $115.51 | +8.22% | 24 | Feb 27, 2026 | |
| INSP Inspire Medical Systems | Maintains: Sector Perform | $90 → $68 | $54.42 | +24.95% | 10 | Feb 12, 2026 | |
| BDX Becton, Dickinson and Company | Maintains: Sector Perform | $210 → $172 | $154.96 | +11.00% | 5 | Feb 10, 2026 | |
| ABT Abbott Laboratories | Maintains: Outperform | $147 → $135 | $101.83 | +32.57% | 18 | Jan 23, 2026 | |
| PEN Penumbra | Downgrades: Sector Perform | $355 → $374 | $329.96 | +13.35% | 16 | Jan 20, 2026 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $625 → $650 | $452.95 | +43.50% | 18 | Dec 17, 2025 | |
| GMED Globus Medical | Maintains: Outperform | $92 → $100 | $90.00 | +11.11% | 9 | Dec 17, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $95 → $100 | $80.84 | +23.70% | 24 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $370 → $380 | $202.46 | +87.69% | 4 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $111 → $118 | $86.42 | +36.54% | 22 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $22 → $17 | $4.10 | +314.63% | 14 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $111 → $101 | $91.40 | +10.50% | 17 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $85 | $63.11 | +34.69% | 5 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $25 | $18.28 | +36.76% | 3 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $332.07 | +31.00% | 19 | Jan 29, 2025 |
Johnson & Johnson
Mar 30, 2026
Reiterates: Outperform
Price Target: $255
Current: $238.41
Upside: +6.96%
Boston Scientific
Mar 30, 2026
Reiterates: Outperform
Price Target: $115
Current: $61.86
Upside: +85.90%
Teleflex
Feb 27, 2026
Maintains: Sector Perform
Price Target: $115 → $125
Current: $115.51
Upside: +8.22%
Inspire Medical Systems
Feb 12, 2026
Maintains: Sector Perform
Price Target: $90 → $68
Current: $54.42
Upside: +24.95%
Becton, Dickinson and Company
Feb 10, 2026
Maintains: Sector Perform
Price Target: $210 → $172
Current: $154.96
Upside: +11.00%
Abbott Laboratories
Jan 23, 2026
Maintains: Outperform
Price Target: $147 → $135
Current: $101.83
Upside: +32.57%
Penumbra
Jan 20, 2026
Downgrades: Sector Perform
Price Target: $355 → $374
Current: $329.96
Upside: +13.35%
Intuitive Surgical
Dec 17, 2025
Maintains: Outperform
Price Target: $625 → $650
Current: $452.95
Upside: +43.50%
Globus Medical
Dec 17, 2025
Maintains: Outperform
Price Target: $92 → $100
Current: $90.00
Upside: +11.11%
Edwards Lifesciences
Dec 5, 2025
Maintains: Outperform
Price Target: $95 → $100
Current: $80.84
Upside: +23.70%
Nov 21, 2025
Maintains: Outperform
Price Target: $370 → $380
Current: $202.46
Upside: +87.69%
Nov 19, 2025
Maintains: Outperform
Price Target: $111 → $118
Current: $86.42
Upside: +36.54%
Nov 11, 2025
Maintains: Sector Perform
Price Target: $22 → $17
Current: $4.10
Upside: +314.63%
Nov 6, 2025
Maintains: Outperform
Price Target: $111 → $101
Current: $91.40
Upside: +10.50%
Oct 31, 2025
Maintains: Outperform
Price Target: $100 → $85
Current: $63.11
Upside: +34.69%
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $25
Current: $18.28
Upside: +36.76%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $332.07
Upside: +31.00%